Results 111 to 120 of about 77,065 (262)
Mutual Insurance as an Element of the Competitive Environment of the Insurance Market
The insurance market of the Russian Federation began to develop very recently, in historical terms, in 1988. New types of insurance have appeared - liability insurance, financial and business risk insurance, health insurance; the list of compulsory types
Irina L. Logvinova
doaj +1 more source
Trends and Current Situation of China's Meat Sector
ABSTRACT As the world's largest meat producer, consumer, and importer, China's meat sector has undergone profound transformation over the past decade, driven by biological crises (e.g., African Swine Fever), environmental policies, and global market integration. This study analyzes the sector's production restructuring, consumption diversification, and
Zengyong Zhu
wiley +1 more source
THE CURRENT STATUS OF LIFE INSURANCE ON THE RUSSIAN FINANCIAL MARKET
The paper considers the current state of the life insurance market, identifies its main problems and their solutions. The development of the life insurance market is analyzed, the economic substance of insurance disclosed as well as the features of the ...
E. Yu. Litvinova +2 more
doaj
Atomistic model of the market of insurance and planetary model of the insurance market
Formulation of the problem. Atomism at the micro level assumes that matter has a finitelyindivisible particle–atom. Another property of matter is gravity, which on a macro scale limits themovement of the planets around the Sun and thus forms the solar system.
Shirinyan, Aram +2 more
openaire +1 more source
Purpose To assess the availability, price transparency, and pricing of platelet‐rich plasma (PRP), bone marrow aspirate concentration, and stem cell injections for knee osteoarthritis (OA) among orthopaedic sports medicine (OSM) practices and alternative clinics in suburban New York and to evaluate the impact of the economic status of a population on ...
Tracy M. Tauro +6 more
wiley +1 more source
Coverage Generosity of Novel Antirheumatic Drugs in Medicare Advantage and Stand‐Alone Part D Plans
Objective We examine coverage of self‐administered disease‐modifying antirheumatic drugs (DMARDs) in Medicare Part D. Methods Using 2022–2026 Part D formulary data, we assessed coverage of the following DMARD classes that treat relapsed rheumatoid arthritis (RA): tumor necrosis factor (TNF) inhibitors, T cell costimulatory modulator, interleukin‐6 (IL ...
Youngmin Kwon +2 more
wiley +1 more source
The effect of a ban on gender-based pricing on risk selection in the German health insurance market. [PDF]
Huang S, Salm M.
europepmc +1 more source
ABSTRACT To investigate the long‐term risk of rheumatoid arthritis (RA) among individuals with autism spectrum disorder (ASD), addressing potential immune comorbidity in ASD populations. A population‐based matched cohort was assembled using Swedish registers, including 46,164 individuals diagnosed with ASD between 1987 and 2017, matched to 4,634,895 ...
Evora Hailin Zhu +10 more
wiley +1 more source
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić +4 more
wiley +1 more source
Same Game, Different Names: Cream-Skimming in the Post-ACA Individual Health Insurance Market. [PDF]
Sacks DW, Drake C, Abraham JM, Simon K.
europepmc +1 more source

